Understand how the US government shutdown affects FDA operations and how LexisNexis supports healthcare readiness.
Printed Drug Labeling Requirements Remain in Effect
read more
LexisNexis Reed Tech
Knowledge Center
Explore our library of blogs, short videos, virtual event recordings and training topics
Medical Devices
Recent Blogs
30 Days Into the U.S. Government Shutdown: What It Means for the FDA and for You
Understand how the US government shutdown affects FDA operations and how LexisNexis supports healthcare readiness.
How a Government Shutdown Impacts the FDA and Healthcare Industry
A government shutdown forces the FDA to scale back operations, delaying new drug and device approvals and slowing healthcare innovation. Learn what continues, what pauses, and why prolonged disruptions matter for patients and providers
Swissmedic Launches UDI Module in swissdamed
Swissmedic has launched the UDI module in swissdamed, marking a key step in Switzerland’s medical device regulation. Voluntary submissions begin in August 2025, with mandatory registration starting July 2026. The system aligns with EUDAMED standards to enhance traceability, compliance, and post-market surveillance.
Navigating the TGA’s Phased Introduction: What Class III & IIb Device Sponsors Need to Know
Australia’s Therapeutic Goods Administration (TGA) is taking a phased approach to regulatory compliance, prioritizing higher-risk medical devices first and gradually expanding requirements to lower-risk categories in the coming years. This structured rollout is designed to manage the complexity of implementation while ensuring that patients and healthcare systems benefit from stronger safeguards at the earliest possible stage.
Pharmaceutical Industry Top Innovators
Explore the key Pharmaceutical Innovators revealed in the latest Innovation Momentum report and their impact on the industry.
FHIR and the Future of Labeling
Learn how manufacturers can adopt FHIR to modernize labeling, enhance traceability, and meet evolving regulatory expectations.
EUDAMED Rollout Delay: What It Means for Medical Device Manufacturers
The European Commission (EC) has missed a key milestone in the rollout of EUDAMED, the central database for medical devices in the EU. According to the previously published timeline, EUDAMED was expected to be declared “fully functional” by July 1, 2025. However, with that date now passed and no notice published in the Official Journal of the European Union (OJEU), the official timeline remains unmet.
Regulatory Survival Guide: FAQs Every Drug and Medical Device Manufacturer Should Know
Navigating drug and device regulations isn’t optional—it’s mission-critical. This Regulatory Survival Guide breaks down the complexities of global compliance, from FDA and EU MDR to Health Canada, UDI, and MoCRA. Whether you’re managing submissions or facing upcoming deadlines, use this FAQ to decode key terms, avoid costly risks, and stay ahead with expert-backed solutions like Compliance-as-a-Service (CaaS).